PARK AEROSPACE CORP quarterly report, Q3 FY2021

Park Aerospace Corp. — Form 10-Q Summary

Reporting-period note: The request identifies 2020 Q3, but the supplied filing is for the 13 weeks ended November 28, 2021 (the company’s fiscal 2022 third quarter), with year-to-date results for 39 weeks. Comparisons are to the periods ended November 29, 2020. Amounts below are in millions unless stated otherwise.

Business context

Park develops and manufactures advanced composite materials, parts and structures for aerospace applications. Its manufacturing facilities are in Kansas; sales are primarily in North America. The filing attributes the sales recovery mainly to improving commercial and business aircraft markets.

Financial results and liquidity

MetricQuarter39 weeks
Net sales$13.9; up 34%$41.1; up 29%
Gross profit / margin$3.8 / 27.7%, versus $2.6 / 24.6%$13.7 / 33.4%, versus $8.9 / 27.8%
Continuing-operations earnings before tax$2.3, up 64%$9.1, up 59%
Net earnings from continuing operations$1.7, versus $1.0$6.5, versus $4.2
Net earnings$1.7, versus $0.9$6.5, versus $3.8
EPS from continuing operationsBasic $0.09; diluted $0.08Basic and diluted $0.32

Improved gross margins reflected higher sales and the partially fixed nature of overhead. SG&A was $1.6 million for the quarter and $4.7 million year to date. Interest and other income fell to $0.08 million for the quarter and $0.29 million year to date, primarily because of lower average investment balances and rates. The prior-year periods included discontinued-operation losses; there were none in the current periods.

  • Cash flow: Operating cash flow was $3.3 million for the 39 weeks, down from $8.6 million. Management cited operating-asset and liability changes, including higher receivables and inventories and lower payables and taxes payable.
  • Cash and investments: Cash and marketable securities totaled $109.6 million at November 28, 2021, versus $116.5 million at February 28, 2021; $29.5 million was held by a foreign subsidiary. Cash alone was $14.0 million. Investing activities used $25.5 million, including $3.6 million of capital expenditures and net purchases of marketable securities.
  • Liquidity and debt: Working capital was $121.3 million and the current ratio was 19.8 to 1.0. The company reported no long-term debt and stated that it had no other long-term obligations beyond disclosed leases and raw-material purchase commitments. Lease liabilities totaled $0.24 million.
  • Capital returns: Dividends paid were $6.1 million year to date; dividends declared were $0.10 per share each quarter. No shares were repurchased during the 39 weeks.

Material changes, outlook and risks

  • Revenue and margins improved year over year, while operating cash flow declined. Interest income also decreased substantially.
  • Management reported inflation in raw materials and other costs, partly mitigated by passing price increases through to customers. Raw-material availability and overseas shipping delays were affecting production and remained risks.
  • A long-term, requirements-based customer contract represents a substantial portion of revenue, but does not guarantee order quantities; forecasts are periodically updated.
  • The Kansas manufacturing expansion was substantially complete. Estimated total facility cost was about $19.3 million; construction-in-progress was $18.1 million and equipment purchase obligations were $0.7 million at period end.
  • Singapore-facility closure restructuring charges were $0.2 million year to date. The filing also reports a $12.6 million non-current income-tax payable and tax expense effects related to the facility and unrecognized tax benefits.
  • Management said financial resources should be sufficient for at least the next 12 months and the foreseeable future. No numerical revenue or earnings guidance was provided. Management noted that aerospace-market recovery and the continuing economic effects of COVID-19 could affect future results.
  • The company reported immaterial litigation and environmental matters involving three sites; it said insurers reimburse 100% of defense and remediation costs for two sites and did not expect known matters to have a material adverse effect.

Important facts for investors to verify

  • Confirm the period: the supplied document is a November 2021 quarter filing, not a 2020 Q3 filing.
  • Track whether improving aerospace demand converts to sustained orders, particularly under the major requirements-based customer contract.
  • Monitor supplier and shipping constraints, production levels, inflation and the company’s ability to pass costs through to customers.
  • Assess operating cash conversion against reported earnings and the ongoing facility expansion’s final cost and remaining commitments.
  • Review marketable-security values, tax exposures and the status of the environmental matters and related insurance recoveries.